Many Couples Choose To Donate Surplus Embryos For Stem Cell Research
By Science Daily,
Science Daily
| 04. 28. 2007
Nearly 50% of couples who were interviewed at least 3 years after undergoing in vitro fertilization (IVF) chose to donate their surplus, stored embryos for stem cell research, according to a report by the Spanish Stem Cell Bank in an April 26, 2007, advanced online publication of Cell Stem Cell, a new publication of Cell Press in affiliation with the International Society for Stem Cell Research.
The key to the couples' decisions, according to the authors of the report, was the complete and clear explanation of their options through an interview process with a legal advisor and embryologist, which helped couples navigate the confusing legal situation and address any concerns they might have had about donation for research purposes. While the findings reflect the interest level among couples in Spain--where the stem cell research environment is fairly open and people have traditionally been supportive of organ and tissue donation--the researchers believe that the results can be generalized to other countries.
"We are convinced that if this type of personal interview and survey were carried out in the U.S.A., at least...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...